RFS according to the MRD level. (A) The RUNX1-RUNX1T1 or CBFB-MYH11 chimeric transcript level in each patient after the completion of 3 courses of HiDAC therapy is shown. (B) Kaplan-Meier estimates of RFS according to the MRD status in 112 CBF-AML patients. Kaplan-Meier estimates of RFS in patients with (C) RUNX1-RUNX1T1 or (D) CBFB-MYH11.